Atomistry » Chlorine » PDB 4fby-4fm6 » 4fc0
Atomistry »
  Chlorine »
    PDB 4fby-4fm6 »
      4fc0 »

Chlorine in PDB 4fc0: Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor

Enzymatic activity of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor

All present enzymatic activity of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor:
2.7.11.1;

Protein crystallography data

The structure of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor, PDB code: 4fc0 was solved by J.K.Yano, K.Aertgeerts, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 30.00 / 2.95
Space group P 41 21 2
Cell size a, b, c (Å), α, β, γ (°) 109.968, 109.968, 145.973, 90.00, 90.00, 90.00
R / Rfree (%) 19.8 / 24.3

Other elements in 4fc0:

The structure of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor also contains other interesting chemical elements:

Fluorine (F) 2 atoms

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor (pdb code 4fc0). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor, PDB code: 4fc0:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 4fc0

Go back to Chlorine Binding Sites List in 4fc0
Chlorine binding site 1 out of 2 in the Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl901

b:32.3
occ:1.00
CL2 A:0T2901 0.0 32.3 1.0
C23 A:0T2901 1.7 30.9 1.0
C16 A:0T2901 2.7 32.4 1.0
C12 A:0T2901 2.7 28.9 1.0
O17 A:0T2901 2.9 34.7 1.0
O11 A:0T2901 3.1 25.8 1.0
C10 A:0T2901 3.1 26.3 1.0
C21 A:0T2901 3.1 36.5 1.0
N22 A:0T2901 3.2 37.2 1.0
CD2 A:LEU504 3.3 21.3 1.0
C18 A:0T2901 3.6 35.8 1.0
CA A:GLY592 3.9 24.6 1.0
N A:ASP593 3.9 25.5 1.0
C15 A:0T2901 4.0 32.0 1.0
C13 A:0T2901 4.0 29.8 1.0
N9 A:0T2901 4.1 23.7 1.0
CG A:LEU504 4.2 23.4 1.0
C A:GLY592 4.2 24.6 1.0
CD2 A:LEU513 4.5 17.6 1.0
C14 A:0T2901 4.5 31.1 1.0
CB A:LEU513 4.6 16.9 1.0
C19 A:0T2901 4.6 35.3 1.0
C20 A:0T2901 4.7 36.0 1.0
CD1 A:LEU504 4.7 23.8 1.0
O A:ILE591 4.8 24.0 1.0
CB A:ASP593 4.9 26.9 1.0
CA A:ASP593 5.0 25.9 1.0

Chlorine binding site 2 out of 2 in 4fc0

Go back to Chlorine Binding Sites List in 4fc0
Chlorine binding site 2 out of 2 in the Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Crystal Structure of Human Kinase Domain of B-Raf with A Dfg-Out Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Cl901

b:36.6
occ:1.00
CL2 B:0T2901 0.0 36.6 1.0
C23 B:0T2901 1.7 32.6 1.0
C16 B:0T2901 2.7 32.7 1.0
C12 B:0T2901 2.7 30.7 1.0
O17 B:0T2901 2.9 33.2 1.0
O11 B:0T2901 3.0 29.0 1.0
C10 B:0T2901 3.1 28.8 1.0
C21 B:0T2901 3.3 33.4 1.0
CD2 B:LEU504 3.3 22.9 1.0
N22 B:0T2901 3.5 33.6 1.0
C18 B:0T2901 3.6 33.5 1.0
CA B:GLY592 3.9 27.8 1.0
C15 B:0T2901 4.0 31.9 1.0
C13 B:0T2901 4.0 30.8 1.0
N B:ASP593 4.1 31.5 1.0
N9 B:0T2901 4.1 26.1 1.0
CG B:LEU504 4.1 23.8 1.0
C20 B:0T2901 4.3 33.1 1.0
C B:GLY592 4.3 28.8 1.0
C14 B:0T2901 4.5 31.2 1.0
CB B:LEU513 4.5 19.1 1.0
O B:ILE591 4.5 24.7 1.0
CD1 B:LEU504 4.6 24.7 1.0
CD2 B:LEU513 4.7 21.1 1.0
C19 B:0T2901 4.9 33.6 1.0
CG2 B:ILE512 5.0 18.6 1.0

Reference:

M.Hirose, M.Okaniwa, T.Miyazaki, T.Imada, T.Ohashi, Y.Tanaka, T.Arita, M.Yabuki, T.Kawamoto, S.Tsutsumi, A.Sumita, T.Takagi, B.C.Sang, J.Yano, K.Aertgeerts, S.Yoshida, T.Ishikawa. Design and Synthesis of Novel Dfg-Out Raf/Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Inhibitors: 3. Evaluation of 5-Amino-Linked Thiazolo[5,4-D]Pyrimidine and Thiazolo[5,4-B]Pyridine Derivatives. Bioorg.Med.Chem. V. 20 5600 2012.
ISSN: ISSN 0968-0896
PubMed: 22883026
DOI: 10.1016/J.BMC.2012.07.032
Page generated: Fri Jul 11 15:10:47 2025

Last articles

Mg in 4JHD
Mg in 4JH6
Mg in 4JH8
Mg in 4JH7
Mg in 4JH3
Mg in 4JH5
Mg in 4JF2
Mg in 4JH2
Mg in 4JH1
Mg in 4JEJ
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy